The monoclonal SB EpCAM antibody yielded more consistent adhesion than the polyclonal R&D EpCAM with the high EpCAM-expressing MCF-7 human breast carcinoma cell line, further illustrating that the latter antibody would not be optimal for CTC detection. This evidence concerns the gene EPCAM and breast carcinoma.